Tagged With Moderna Stock

Pfizer and AstraZeneca slide as Moderna's rival COVID-19 vaccine shows strong efficacy

Matthew Fox

Moderna leaps 9% in premarket after results show its COVID-19 vaccine is almost 95% effective

Shalini Nagarajan

Moderna jumps 5% after Fauci says its upcoming COVID-19 vaccine trial data may be positive

Shalini Nagarajan

S&P 500 surges, flirts with record close as investor optimism persists

Carmen Reinicke

Dow rises 270 points as investors react to encouraging vaccine news

Carmen Reinicke

Moderna surges 11% after Trump says US government reached deal for 100 million doses of its coronavirus vaccine

Carmen Reinicke

US stocks rise as investors await major earnings, coronavirus stimulus plan

Carmen Reinicke

US stocks trade mixed as investors await major earnings, coronavirus stimulus plan

Carmen Reinicke

Moderna skyrockets 11% after receiving additional $472 million of funding, starting Phase 3 trial of COVID-19 vaccine

Carmen Reinicke

Dow climbs 228 points on positive vaccine data, big Goldman earnings beat

Carmen Reinicke

Moderna will surge another 60% on the value of its potential coronavirus vaccine, according to one Wall Street firm

Carmen Reinicke

Dow rallies 260 points on positive vaccine-trial data, blockbuster Goldman earnings

Carmen Reinicke

Moderna shares soar 17% after early coronavirus vaccine trial produces antibodies in all patients

Ben Winck

The so-called reopening trade surges on Moderna vaccine trial success

Carmen Reinicke

S&P 500 slides on California reopening rollback after briefly erasing post-COVID losses

Ben Winck

Moderna is poised to surge another 45% in the next year, COVID-19 vaccine could generate more than $5 billion in annual sales, Jefferies says

Carmen Reinicke

Investors boosted their stock-market bets in May for the first time in 4 months, TD Ameritrade says

Ben Winck

Morgan Stanley now sees Moderna shares spiking 26% from current levels, cites 65% chance of success for virus vaccine

Carmen Reinicke

Dow spikes 912 points as vaccine progress spurs economic-reopening optimism

Carmen Reinicke

These are the 5 scientists and executives getting the richest off Moderna's spike to record highs

Ben Winck